Mannatech Inc. is a publicly traded, multinational multi-level marketing firm that sells dietary supplements and personal care products. It was founded in November 1993 by Samuel Caster, and is headquartered in Flower Mound, Texas. The company's stock is traded on the NASDAQ exchange under the symbol MTEX. As of 2017, Mannatech employed 252 people and sold its products through some 220,000 independent sales associates.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| MTEX | MANNATECH INC | 2026-05-18 14:04:31 | 3.98 | -0.48 | -10.66 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MTEX | 0001056358 | MANNATECH INC | US5637712036 | — | 752508900 | Nasdaq | 2833 | Medicinal Chemicals & Botanical Products | 1231 | TX | 1410 LAKESIDE PARKWAY | FLOWER MOUND | TX | 75028 | UNITED STATES | US | 9724717400 | 1410 LAKESIDE PARKWAY, FLOWER MOUND, TX, 75028 | 1410 LAKESIDE PARKWAY, FLOWER MOUND, TX, 75028 | — | Dietary supplements | 1993-11-04 | Landen Fredrick | 252 | http://mannatech.com | 9,875,105 | 2,742,857 | 1,929,670 | Mannatech Inc. is a publicly traded, multinational multi-level marketing firm that sells dietary supplements and personal care products. It was founded in November 1993 by Samuel Caster, and is headquartered in Flower Mound, Texas. The company's stock is traded on the NASDAQ exchange under the symbol MTEX. As of 2017, Mannatech employed 252 people and sold its products through some 220,000 independent sales associates. | 2026-05-14 20:05:53 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 9,875,105 | 2,082,867 | 26.73 | 1,929,670 | 28,740 | 1.5119 |
| 2024 | 7,792,238 | -3,905,550 | -33.3871 | 1,900,930 | 16,116 | 0.855 |
| 2023 | 11,697,788 | -5,438,996.5 | -31.7387 | 1,884,814 | 11,206 | 0.5981 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| James Clavijo | Chief Financial Officer | 2025 | 275,000 | 5,288 | — | 0 | 9,411 | 289,699 |
| Landen Fredrick | President, Chief Executive Officer | 2025 | 350,577 | 6,923 | — | 0 | 11,330 | 368,830 |
| Landen Fredrick | President, Chief Executive Officer | 2024 | 321,500 | 6,250 | — | 0 | 3,189 | 330,939 |
| James Clavijo | Chief Financial Officer | 2024 | 147,212 | 5,288 | — | 0 | 4,933 | 157,433 |
| Landen Fredrick | Chief Operating Officer, President | 2023 | 312,000 | 6,000 | — | 0 | 22,083 | 340,083 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 170 |
| 2024 | 189 |
| 2023 | 213 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 108,038,000 | 117,866,000 | 131,955,000 |
| Cost Of Revenue | 27,079,000 | 26,406,000 | 29,090,000 |
| Gross Profit | 80,959,000 | 91,460,000 | 102,865,000 |
| Research And Development Expenses | 800,000 | 700,000 | 800,000 |
| General And Administrative Expenses | 39,658,000 | 41,722,000 | 48,613,000 |
| Operating Expenses | 81,385,000 | 90,031,000 | 103,829,000 |
| Operating Income | -426,000 | 1,429,000 | -964,000 |
| Net Income | -15,213,000 | 2,490,000 | -2,239,000 |
| Earnings Per Share Basic | -8 | 1.32 | -1.2 |
| Earnings Per Share Diluted | -8 | 1.32 | -1.2 |
| Weighted Average Shares Outstanding Basic | 1,901,000 | 1,885,000 | 1,866,000 |
| Weighted Average Shares Outstanding Diluted | 1,901,000 | 1,885,000 | 1,866,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 6,185,000 | 11,396,000 | 7,731,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 1,000 | 19,000 | 91,000 |
| Inventories | 10,123,000 | 10,405,000 | 14,535,000 |
| Non Trade Receivables | 736,000 | 737,000 | 465,000 |
| Other Assets Current | 1,701,000 | 1,755,000 | 1,774,000 |
| Total Assets Current | 20,576,000 | 26,121,000 | 27,664,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 2,227,000 | 2,858,000 | 4,147,000 |
| Other Assets Non Current | 2,751,000 | 2,644,000 | 7,066,000 |
| Total Assets Non Current | 3,100,000 | 9,935,000 | 13,542,000 |
| Total Assets | 29,993,000 | 36,056,000 | 41,206,000 |
| Accounts Payable | 2,410,000 | 2,070,000 | 4,010,000 |
| Deferred Revenue | 3,086,000 | 3,000,000 | 4,800,000 |
| Short Term Debt | 0 | 84,000 | — |
| Other Liabilities Current | 3,128,000 | 3,832,000 | 6,779,000 |
| Total Liabilities Current | 18,735,000 | 20,896,000 | 25,780,000 |
| Long Term Debt | 2,750,000 | — | 956,000 |
| Other Liabilities Non Current | 1,340,000 | 1,390,000 | 3,986,000 |
| Total Liabilities Non Current | 16,481,000 | 6,546,000 | 4,942,000 |
| Total Liabilities | 35,216,000 | 27,442,000 | 30,722,000 |
| Common Stock | 0 | 0 | 0 |
| Retained Earnings | -14,024,000 | 1,189,000 | -1,301,000 |
| Accumulated Other Comprehensive Income | -4,669,000 | -5,666,000 | -1,015,000 |
| Total Shareholders Equity | -5,223,000 | 8,614,000 | 10,484,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 1,092,000 | 1,534,000 | 1,628,000 |
| Share Based Compensation Expense | 379,000 | 291,000 | 278,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | -173,000 | -344,000 | 391,000 |
| Change In Inventories | -313,000 | -2,474,000 | 272,000 |
| Change In Non Trade Receivables | -4,000 | 277,000 | 42,000 |
| Change In Other Assets | 226,000 | -625,000 | 226,000 |
| Change In Accounts Payable | 315,000 | -1,857,000 | -351,000 |
| Change In Other Liabilities | -2,912,000 | -4,289,000 | -2,308,000 |
| Cash From Operating Activities | -2,963,000 | 2,261,000 | -2,370,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 1,353,000 | 297,000 | 748,000 |
| Acquisition Of Business | — | — | — |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -1,353,000 | -285,000 | -747,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | 0 | — | 748,000 |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | — | 0 | 176,000 |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | 327,000 | — | — |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | -561,000 | 1,961,000 | -1,903,000 |
| Change In Cash | -5,546,000 | 3,128,000 | -5,810,000 |
| Cash At End Of Period | 6,185,000 | 11,396,000 | 7,731,000 |
| Income Taxes Paid | 429,000 | 829,000 | 2,551,000 |
| Interest Paid | 512,000 | 337,000 | 211,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | -8 | 1.32 | -1.2 |
| Price To Earnings Ratio | -1.0312 | 10.1742 | -6.75 |
| Earnings Growth Rate | -706.0606 | -210 | -48.9362 |
| Price Earnings To Growth Ratio | 0.0015 | -0.0484 | 0.1379 |
| Book Value Per Share | -2.7475 | 4.5698 | 5.6184 |
| Price To Book Ratio | -3.0027 | 2.9389 | 1.4417 |
| Ebitda | -13,286,000 | 4,574,000 | 1,944,000 |
| Enterprise Value | 12,248,250 | — | 8,339,600 |
| Dividend Yield | 0 | — | 0.0495 |
| Dividend Payout Ratio | 0 | — | -0.3341 |
| Debt To Equity Ratio | -0.5265 | — | 0.0912 |
| Capital Expenditures | 461,000 | 245,000 | 2,016,000 |
| Free Cash Flow | -3,424,000 | 2,016,000 | -4,386,000 |
| Return On Equity | 2.9127 | 0.2891 | -0.2136 |
| One Year Beta | 0.4643 | -0.1918 | -0.2186 |
| Three Year Beta | 0.1457 | 0.0649 | 0.2398 |
| Five Year Beta | 0.2497 | 0.3886 | 0.4255 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Rameson Tyler | Director | 2026-01-02 | 4,790 | A | 306,673 |
| FREDRICK J STANLEY | Director | 2026-01-02 | 4,790 | A | 361,765 |
| TOTH ROBERT | Director | 2026-01-02 | 4,790 | A | 95,920 |
| John Seifrick A | Director | 2026-01-02 | 4,790 | A | 13,746 |
| Robbins Kevin Andrew | Director | 2026-01-02 | 4,790 | A | 26,233 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Advisory Services Network, LLC | 2026-03-31 | 180 | 30 | 6 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 2026-03-31 | 173,724 | 28,954 | 6 |
| JONES FINANCIAL COMPANIES LLLP | 2026-03-31 | 909 | 150 | 6.06 |
| MORGAN STANLEY | 2026-03-31 | 14 | 2 | 7 |
| NATIONAL BANK OF CANADA /FI/ | 2026-03-31 | 179 | 30 | 5.9667 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| FIDELITY CONCORD STREET TRUST | 2026-02-28 | Fidelity Extended Market Index Fund | FSMAX | 6,376 | 44,121.92 | 0.0001 |
| FIDELITY CONCORD STREET TRUST | 2026-02-28 | Fidelity Nasdaq Composite Index Fund | FNCMX | 1,393 | 9,639.56 | 0.0 |
| FIDELITY CONCORD STREET TRUST | 2026-02-28 | Fidelity Series Total Market Index Fund | FCFMX | 1,681 | 11,632.52 | 0.0 |
| FIDELITY CONCORD STREET TRUST | 2026-02-28 | Fidelity Total Market Index Fund | FSKAX | 422 | 2,920.24 | 0.0 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 2026-01-31 | U.S. CORE EQUITY 2 PORTFOLIO - INSTITUTIONAL CLASS | DFQTX | 867 | 6,563.19 | 0.0 |